|
William D. Schwieterman M.D. joined our board in June 2007. Dr. Schwieterman a board-certified internist and a rheumatologist was formerly Chief of the Medicine Branch and Chief of the Immunology and Infectious Disease Branch in the Division of Clinical Trials at the Food and Drug Administration (FDA). In these and other capacities Dr. Schwieterman served 10 years at the FDA in the Center for Biologics overseeing a wide range of clinical development programs for a large number of therapeutic candidates. He worked closely with industrial sponsors developing new drugs in a variety of therapeutic areas including pulmonary medicine neurology sepsis hepatitis rheumatology infectious disease solid organ transplantation and wound-healing and also with FDA reviewers of vaccines devices (CDRH) and oncology products. Dr. Schwieterman helped author the FDA's "Good Review Practices" for investigational products and was instrumental in developing several guidance documents for industry. He currently serves as an independent consultant to biotechnology and pharmaceutical companies focusing on clinical drug development and regulatory matters. | 